-
TCF25 Links Glucose Starvation to Lysosomal Cell Death
2026-09-28
Ren et al. identify TCF25 as a nutrient-stress regulator that increases V-ATPase-dependent lysosomal acidification, supporting autophagy and ATP production during glucose starvation but promoting ferritinophagy-associated lysosomal cell death during prolonged stress. The study also links TCF25 deficiency to protection from hepatic ischemia-reperfusion injury, providing a mechanistic framework for studying lysosomal control of metabolic adaptation and tissue damage.
-
Recombinant Human Growth Hormone: Assay Workflows
2026-09-28
Translate growth hormone biology into a practical chondrocyte workflow, from dose-ranging to IGFBP2–THBS1 pathway readouts. This guide pairs a recent mechanistic study with assay-design and troubleshooting advice for research use of recombinant somatotropin.
-
Taltirelin Reduces Acute and Chronic Itch in Mice
2026-09-27
A 2024 mouse study reports that Taltirelin suppresses scratching in both chloroquine-induced acute itch and diphenylcyclopropenone-induced chronic itch. The findings extend research on this thyrotropin-releasing hormone analog beyond pain, while leaving the responsible pathways and clinical relevance to be established.
-
Resiquimod in Thermal Tumor Ablation
2026-09-26
How Resiquimod (R-848) links innate immune activation with heat-protective, responsive delivery—and what translational researchers should validate before moving from preclinical promise to therapeutic strategy.
-
SGI-1027 and Everolimus in Renal Cancer
2026-09-25
A 2024 study reports that SGI-1027, a DNMT1 inhibitor, induces vacuolation and methuosis in renal cancer cells and cooperates with everolimus to suppress tumor-associated behaviors. The combination is associated with lysosomal membrane permeability, apoptosis, and GSDME-dependent pyroptosis, with antitumor activity also observed in a subcutaneous model.
-
Taltirelin Acetate: From Dopamine to Translation
2026-09-25
Taltirelin acetate offers translational researchers a way to investigate sustained TRH-receptor signaling across neurobiology and formulation research. This article examines the evidence in a Parkinson’s disease model, separates demonstrated findings from broader mechanistic hypotheses, and outlines practical study-design choices and cross-domain limits.
-
PERK-Linked Pyroptosis in Disc Degeneration
2026-09-24
A 2025 study links unresolved endoplasmic reticulum stress in nucleus pulposus cells to pyroptosis through a PERK/eIF2α/ATF4-dependent JAK1–STAT3 pathway. Its combination of pathway knockdown and inflammatory cell-death readouts gives researchers a mechanistic framework for testing how ER stress contributes to intervertebral disc degeneration, while leaving important questions about causality and in vivo relevance open.
-
Panobinostat (LBH589) in Epigenetic Cancer Assays
2026-09-24
Use Panobinostat to connect broad HDAC inhibition with histone acetylation, cell-cycle changes, and apoptosis readouts in cancer models. A workflow informed by a recent Pol II study helps distinguish transcriptional effects from cell-death mechanisms without assuming that LBH589 degrades Pol II.
-
Pregnenolone Carbonitrile for PXR Liver Studies
2026-09-23
Use Pregnenolone Carbonitrile to probe rodent PXR signaling, CYP3A induction, and disease-associated changes in hepatic drug handling. A recent MASH pharmacokinetics study offers a practical framework for pairing PXR experiments with transporter, tissue-distribution, and intracellular-accumulation measurements.
-
JNJ-10198409: Reliable PDGF Assays
2026-09-23
A scenario-driven guide to using JNJ-10198409 (SKU C5737) in PDGF-BB receptor, viability, proliferation, and cytotoxicity workflows. It connects product-backed potency, solubility, storage, and assay-design considerations with practical controls for reproducible interpretation.
-
Nintedanib (BIBF 1120) in Translational Research
2026-09-22
Nintedanib (BIBF 1120) gives researchers a single, experimentally tractable probe of VEGFR, FGFR, and PDGFR signaling across cancer, angiogenesis, and fibrosis models. This guide converts its kinase profile into practical assay workflows, ATRX-informed study designs, and troubleshooting strategies.
-
PTEN mRNA: A Translational Route to PI3K/Akt Control
2026-09-22
A mechanistic and strategic guide to using EZ Cap™ Human PTEN mRNA (ψUTP) for restoring PTEN expression, interrogating PI3K/Akt biology, and designing more reproducible nanoparticle-enabled cancer research workflows.
-
Genotyping Kit for target alleles: Fast PCR
2026-09-21
K1026 streamlines PCR-ready DNA preparation from insects, tissues, fishes, and cells without phenol extraction or spin columns. This article shows how to build a single-tube workflow, adapt it for allele screening, and troubleshoot common failures in model-organism and cell-based studies.
-
miRNA–mRNA Control of Juvenile Hormone Biosynthesis
2026-09-21
The reference study identifies coordinated miRNA–mRNA modules that release multiple juvenile hormone biosynthetic genes in the locust corpus allatum during vitellogenesis. By combining transcriptomics, expression validation, reporter assays, and agomiR perturbation, it links post-transcriptional regulation with juvenile hormone-dependent vitellogenin production and ovarian development.
-
Surface-Cleaned Black Phosphorus Nanosheets in AKI
2026-09-20
A 2026 Theranostics study shows that hydrogen-reduced, surface-cleaned black phosphorus nanosheets can chelate labile iron, suppress tubular ferroptosis, and moderate macrophage activation in acute kidney injury. The work links material surface chemistry with iron homeostasis and immune crosstalk, providing a mechanistic framework for nanoparticle-based AKI intervention.